ClinConnect ClinConnect Logo
Search / Trial NCT06645717

Neuromotor Development and Motor Related Health Care in Children with a High Risk Neonatal Period

Launched by KAROLINSKA INSTITUTET · Oct 14, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Brain Hie Sga Preterm Neurodevelopment Motor Related Healthcare Children Motor Function

ClinConnect Summary

This clinical trial is looking at how common motor and neurological disorders are in Swedish infants who faced serious health challenges shortly after birth, such as being born prematurely or having low oxygen levels. The study aims to understand if these children, when they reach ages 2 and 5.5 years, are receiving the necessary motor-related health care to help them develop properly.

To be part of this study, children need to be enrolled in a specific health registry and have a follow-up plan for the ages mentioned. There are no specific exclusions, so if they meet the criteria, they can participate. While the trial is not yet recruiting, families can expect that their children will be assessed for any motor or neurological issues and the care they receive will be evaluated over time. This information will help improve care for similar children in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Included in the SNQ registry and having a follow-up protocol for 2 and/or 5 years of age.
  • Exclusion Criteria:
  • None if the above inclusion criteria ar true.

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Patients applied

0 patients applied

Trial Officials

Maria Örtqvist, PhD

Principal Investigator

Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported